Effect of pioglitazone and metformin fixed-dose combination on glycaemic control in untreated patients

被引：0
|
作者：
Zhao, Z. [1 ]
Spanheimer, R. [2 ]
Perez, A. [1 ]
机构：
[1] Takeda Global Res & Dev Ctr Inc, Lake Forest, IL USA
[2] Takeda Pharmaceut N Amer Inc, Deerfield, IL USA
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
854
引用
收藏
页码：S335 / S335
页数：1
相关论文
共 50 条
  • [21] Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes
    Hu, Jingbo
    Zou, Ping
    Zhang, Shuo
    Zhou, Minzhi
    Tan, Xueying
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (18) : 2471 - 2477
  • [22] Rosiglitazone and metformin fixed-dose combination provides superior glycaemic control compared to metformin and rosiglitazone monotherapies, and was well tolerated in drug-naive type 2 diabetes patients
    Chou, H
    Rood, J
    Biswas, N
    Strow, L
    Krebs, J
    Parikh, S
    Huang, C
    Cobitz, AR
    DIABETOLOGIA, 2005, 48 : A278 - A279
  • [23] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETOLOGIA, 2010, 53
  • [24] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [25] A PHARMACOKINETIC COMPARISON BETWEEN FIXED-DOSE COMBINATION AND SEPARATE TABLETS OF ROSUVASTATIN AND METFORMIN IN FED STATE AND FOOD EFFECT OF FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS.
    Kim, E.
    Rhee, S-J.
    Kim, Y.
    Oh, J.
    Suh, H.
    Lee, Y.
    Lee, Y.
    Cho, J-Y.
    Yu, K-S.
    Lee, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S40 - S40
  • [26] Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
    Lingvay, Ildiko
    Beetz, Nadine
    Sennewald, Regina
    Schuler-Metz, Annette
    Bertulis, Julia
    Loley, Christina
    Lang, Benjamin
    Lippert, Caroline
    Lee, Jisoo
    Manning, Linda Shapiro
    Terada, Derek
    POSTGRADUATE MEDICINE, 2020, 132 (04) : 337 - 345
  • [27] Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
    Choi, Hyang-Ki
    Oh, Minkyung
    Kim, Eun Ji
    Song, Geun Seog
    Ghim, Jong-Iyul
    Shon, Ji-Hong
    Kim, Ho-Sook
    Shin, Jae-Gook
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (02) : 147 - 153
  • [28] Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control
    Raskin, P.
    Lewin, A.
    Reinhardt, R.
    Lyness, W.
    DIABETES OBESITY & METABOLISM, 2009, 11 (10): : 947 - 952
  • [29] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
  • [30] Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and coadministration of sitagliptin and metformin.
    Miller, J.
    Migoya, E. M.
    Gutierrez, M.
    Zheng, W.
    Johnson-Levonas, A. O.
    Wagner, J. A.
    Gottesdiener, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S58 - S58
12345